These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7318434)

  • 1. CEA as a cancer marker sponsored by the National Cancer Institute, assisted by the Office for Medical Applications of Research, Office of the Director, NIH.
    Conn Med; 1981 Nov; 45(11):735-7. PubMed ID: 7318434
    [No Abstract]   [Full Text] [Related]  

  • 2. CEA (carcinoembryonic antigen): its role as a marker in the management of cancer.
    J La State Med Soc; 1981 Jul; 133(7):97-100. PubMed ID: 7276696
    [No Abstract]   [Full Text] [Related]  

  • 3. NIH Consensus development conference summary: CEA as a cancer marker.
    J Tenn Med Assoc; 1982 Jan; 75(1):24-5. PubMed ID: 7087455
    [No Abstract]   [Full Text] [Related]  

  • 4. National Institutes of Health consensus development conference statement CEA (carcinoembryonic antigen): its role as a marker in the management of cancer.
    J Ark Med Soc; 1981 Jun; 78(1):65-8. PubMed ID: 6454681
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of primary breast cancer: management of local disease. Sponsored by the National Cancer Institute assisted by the Office for Medical Applications of Research, NIH.
    Conn Med; 1979 Sep; 43(9):569-70. PubMed ID: 583268
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant chemotherapy of breast cancer. Sponsored by the National Cancer Institute, assisted by the Office for Medical Applications of Research, NIH.
    Conn Med; 1980 Nov; 44(11):721-3. PubMed ID: 7226778
    [No Abstract]   [Full Text] [Related]  

  • 7. National Institutes of Health Consensus Development Conference Statement: CEA (carcinoembryonic antigen): its role as a marker in the management of cancer.
    N C Med J; 1981 Sep; 42(9):660-4. PubMed ID: 6946297
    [No Abstract]   [Full Text] [Related]  

  • 8. Cervical cancer screening: the Pap smear. Sponsored by the National Cancer Institute. Assisted by the Office for Medical Applications of Research, NIH.
    Conn Med; 1981 Jan; 45(1):33-6. PubMed ID: 7226788
    [No Abstract]   [Full Text] [Related]  

  • 9. Indications for tonsillectomy and adenoidectomy: Phase I. Sponsored by the National Cancer Institute assisted by the Office for Medical Applications of Research, NIH.
    Conn Med; 1979 Dec; 43(12):791-2. PubMed ID: 540502
    [No Abstract]   [Full Text] [Related]  

  • 10. National Institutes of Health Consensus Development Conference Statement-CEA (carcinoembryonic antigen): its role as a marker in the management of cancer.
    Md State Med J; 1981 Jul; 30(7):48-50. PubMed ID: 7278383
    [No Abstract]   [Full Text] [Related]  

  • 11. Coronary artery bypass surgery. Sponsored by the National Heart, Lung, and Blood Institute, assisted by the Office of Medical Applications of Research, NIH.
    Conn Med; 1981 Oct; 45(10):649-53. PubMed ID: 6975699
    [No Abstract]   [Full Text] [Related]  

  • 12. Consensus Development Summaries. Cesarean childbirth. Sponsored by the National Institute of Child Health and Human Development: assisted by the Office for Medical Applications of Research, NIH.
    Conn Med; 1981 Mar; 45(3):155-62. PubMed ID: 7238024
    [No Abstract]   [Full Text] [Related]  

  • 13. National Institutes of Health Consensus Development Conference Statement. CEA (carcinoembryonic antigen): its role as a marker in the management of cancer.
    J Okla State Med Assoc; 1981 Oct; 74(10):338-40. PubMed ID: 7338736
    [No Abstract]   [Full Text] [Related]  

  • 14. Consensus Development Summaries. Estrogen use and postmenopausal women. Sponsored by the National Institute on Aging, assisted by the Office for Medical Applications of Research, NIH.
    Conn Med; 1980 Feb; 44(2):85, 87-8. PubMed ID: 7363614
    [No Abstract]   [Full Text] [Related]  

  • 15. National Institutes of Health Consensus Development Conference on Liver Transplantation. Sponsored by the National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases and the National Institutes of Health Office of Medical Applications of Research.
    Hepatology; 1984; 4(1 Suppl):1S-110S. PubMed ID: 6363251
    [No Abstract]   [Full Text] [Related]  

  • 16. Carcinoembryonic antigen. The current status.
    Neville AM
    Arch Pathol Lab Med; 1981 Jun; 105(6):281-2. PubMed ID: 6894524
    [No Abstract]   [Full Text] [Related]  

  • 17. CEA as a cancer marker.
    Consens Dev Conf Summ Natl Inst Health; 1980; 3():55-8. PubMed ID: 7023817
    [No Abstract]   [Full Text] [Related]  

  • 18. Strengthening the Office of the Director of NIH: views of the American Federation for Clinical Research submitted for consideration by the Advisory Committee on the National Institutes of Health, Department of Health and Human Services.
    Clin Res; 1990 Apr; 38(2):231-3. PubMed ID: 2338021
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: the Applications of Bioinformatics in Cancer Detection Workshop.
    Kapetanovic IM; Umar A; Khan J
    Ann N Y Acad Sci; 2004 May; 1020():1-9. PubMed ID: 15208178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Office of Recombinant DNA Activities; recombinant DNA research: action under the guidelines. National Institutes of Health (NIH), PHS, DHHS. Notice of action under the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines).
    Fed Regist; 1999 May; 64(90):25361-2. PubMed ID: 10558523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.